Genta ist am Freitag mit Tesetaxel bei der Poster Session 5 dabei. 5:00 pm - 7:00 pm | Poster Session 5 - Exhibit Halls A-B |
P5-19-11 | Tesetaxel, an Oral Taxane, as First-Line Therapy for Women with Metastatic Breast Cancer Schwartzberg L, Rubin P, Patnaik A, Itri L, Olson AL, Seidman AD. The West Clinic, Memphis, TN; The Moses H. Cone Regional Cancer Center, Greensboro, NC; START Center - South Texas Accelerated Research Therapeutics, San Antonio, TX; Genta Incorporated, Berkeley Heights, NJ; Memorial Sloan-Kettering Cancer Center, New York, NY. |
http://sabcs.org/ProgramSchedule/PosterSessions.asp?SessionGroupID=99 |